You searched for "electives"
The effects of ab-interno XEN gel implantation on postural IOP elevations
The study involved 18 patients with XEN gel implants, 30 patients who had trabeculectomy, and 30 medically managed glaucoma patients. All patients in XEN gel implant and trabeculectomy groups had at least 11 months of follow-up following successful surgery resulting...HS-UK ‘Improving Outcomes’ Clinical Decisions & Management Course
The ‘Improving Outcomes’ Biometry: Clinical Decisions & Management course focuses on how biometry measurements can be used to guide clinical decision making. This includes evidence-based approaches to selecting the appropriate formulae, planning for more complex cataract cases, and approaches to...Evolving towards an interventional glaucoma mindset
Traditionally, a newly diagnosed glaucoma patient would be treated first with medical therapy. As the disease progressed or the initial intervention failed to adequately control intraocular pressure (IOP), clinicians would add more drops, selective laser trabeculoplasty (SLT), repeated SLT and...New College of Optometrists President and Council members announced
The College of Optometrists welcomed a new President and seven new Council members at its AGM, held during the College’s clinical conference, Optometry Tomorrow 2024 - now incorporating BCLA Focus - in Telford on 29 April.Stem cell therapy for Parkinson’s disease: researching for an effective cure
Neurodegenerative diseases are characterised by the chronic and progressive loss of neurons, which in turn results in loss of cognitive and physical functions. The World Health Organization has estimated that the disability-adjusted life years lost from neurological disease was about...
The inflammatory side-effect of Brimonidine
Brimonidine is a well established selective alpha-2 adreno-receptor agonist, used to lower intraocular pressure. This case series reports on 19 eyes affected by brimonidine induced uveitis. Mean age of the patients was 74 years and mean duration of brimonidine use...
